Enterprise information has been authenticated 
Headquartered in Shenzhen, China, Edge Medical is a seasoned practitioner in surgical robotics innovation. Backed by renowned investors such as HongShan, Temasek Holdings, and OrbiMed, we are driven by the mission to "Advancing Surgery, Elevating Care," delivering high-quality robotic solutions to healthcare institutions worldwide.
Edge Medical® has a interdisciplinary R&D and manufacturing team of over a decade of. With over a decade of technological accumulation and refinement, our core surgical robotic systems are industry benchmarking. Our company has established a robust and complete product portfolio, including multi-port endoscopic surgical robots, single-port endoscopic surgical robots, and bronchoscopic surgical robots.All the products are now available on the market.
In 2024, we conducted a groundbreaking transcontinental tele-surgery spanning from Rome and Bordeaux in Europe to Beijing, China, setting a new milestone in the history of human surgery.
With employees and partners spanning over25 countries, Edge Medical aims to advance surgical practices through technological innovation, accelerate the global adoption of robotic surgery, and improve patient outcomes worldwide.
Edge Medical is a Chinese company to offer multi-port, single-port, and bronchoscopic surgical robotsExtraordinary R&D Capabilities — Established a comprehensive proprietary intellectual property system with core technology modules in surgical robot. Over 736 patents grants and applications globally.
Support from leading investors worldwide — With RMB360 million registered capital, Edge Medical has successfully attracted investors with the deepest understanding of medical technology, including Boyu, Temasek, HongShan, 3H Health, LYFE Capital, China State-Owned Enterprise Mixed Ownership Reform Fund and OrbiMed since established. Edge Medical was valued at over US$1.5 billion by the Cross-over round in December 2021.